Live Nation Entertainment, Inc. (LYV) Reaches $48.98 High on Jun, 29; Maverick Capital LTD Has Lowered Edwards Lifesciences (EW) Holding

Live Nation Entertainment, Inc. (NYSE:LYV) Logo

The stock of Live Nation Entertainment, Inc. (NYSE:LYV) reached all time high today, Jun, 29 and still has $51.92 target or 6.00% above today’s $48.98 share price. This indicates more upside for the $10.23 billion company. This technical setup was reported by Barchart.com. If the $51.92 PT is reached, the company will be worth $613.98 million more. The stock increased 0.60% or $0.29 during the last trading session, reaching $48.98. About 178,964 shares traded. Live Nation Entertainment, Inc. (NYSE:LYV) has risen 26.81% since June 29, 2017 and is uptrending. It has outperformed by 14.24% the S&P500. Some Historical LYV News: 15/03/2018 – LIVE NATION ENTERTAINMEN TO OFFER $800M NOTES; 24/04/2018 – MECU Signs Naming Rights Sponsorship of Pier Six Pavilion in Baltimore, MD; 26/05/2018 – DEADLINE ALERT: Shareholder Class Action Against Live Nation Entertainment, Inc. — LYV; 15/03/2018 – Moody’s: Live Nation’s Speculative Grade Liquidity Rating Was Affirmed at SGL-1; 11/05/2018 – The Klein Law Firm Reminds Investors of a Class Action on Behalf of Live Nation Entertainment, Inc. Shareholders and a Lead Plaintiff Deadline of June 18, 2018; 04/04/2018 – State Bank & Trust Company Signs Naming Rights Sponsorship of Chastain Park Amphitheatre in Atlanta, Georgia; 08/05/2018 – J. Cole Announces North American KOD Tour With Special Guest Young Thug; 24/05/2018 – Ticketmaster Presence Wins “Best In Sports Technology” At Sports Business Awards; 19/04/2018 – Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Live Nation Entertainment, Inc. (LYV) and Encourages Investors to Contact the Firm; 25/05/2018 – New York Post: Live Nation investor withdraws suit over executive bonuses

Maverick Capital Ltd decreased Edwards Lifesciences Corp (EW) stake by 5.85% reported in 2018Q1 SEC filing. Maverick Capital Ltd sold 4,650 shares as Edwards Lifesciences Corp (EW)’s stock declined 0.56%. The Maverick Capital Ltd holds 74,810 shares with $10.44M value, down from 79,460 last quarter. Edwards Lifesciences Corp now has $30.90 billion valuation. The stock decreased 0.08% or $0.12 during the last trading session, reaching $146.61. About 124,508 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 19.08% since June 29, 2017 and is uptrending. It has outperformed by 6.51% the S&P500. Some Historical EW News: 24/04/2018 – EDWARDS LIFESCIENCES – CONTINUES TO EXPECT THVT FY UNDERLYING SALES GROWTH RATE TO BE AT HIGHER END OF 11 PCT TO 15 PCT; 20/04/2018 – Edwards Lifesciences is simplifying heart surgery, and it’s a buy by @JimCramer’s standards; 24/04/2018 – After-hours buzz: TXN, WYNN, EW & more; 24/04/2018 – Edwards Lifesciences 1Q EPS 96c; 01/05/2018 – Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement; 21/03/2018 – Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe; 14/05/2018 – Edwards Lifesciences To Webcast Annual Meeting Of Stockholders; 24/04/2018 – EDWARDS LIFESCIENCES CORP FY2018 SHR VIEW $4.53, REV VIEW $3.85 BLN — THOMSON REUTERS l/B/E/S; 24/04/2018 – Edwards Lifesciences Sees FY Sales $3.5B-$3.9B; 21/05/2018 – Edwards Announces Key Events For EuroPCR 2018

Analysts await Live Nation Entertainment, Inc. (NYSE:LYV) to report earnings on August, 8. They expect $0.26 earnings per share, down 10.34% or $0.03 from last year’s $0.29 per share. LYV’s profit will be $54.32M for 47.10 P/E if the $0.26 EPS becomes a reality. After $-0.24 actual earnings per share reported by Live Nation Entertainment, Inc. for the previous quarter, Wall Street now forecasts -208.33% EPS growth.

Among 4 analysts covering Live Nation Entertainment (NYSE:LYV), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Live Nation Entertainment had 5 analyst reports since January 10, 2018 according to SRatingsIntel. The rating was upgraded by Citigroup on Monday, April 9 to “Buy”. The firm has “Outperform” rating given on Friday, May 4 by Evercore. Northcoast upgraded the stock to “Buy” rating in Sunday, April 22 report. The stock of Live Nation Entertainment, Inc. (NYSE:LYV) earned “Buy” rating by Guggenheim on Wednesday, January 10. The rating was maintained by Guggenheim on Wednesday, February 28 with “Buy”.

Since June 6, 2018, it had 0 insider purchases, and 2 sales for $296,966 activity. HINSON JEFFREY T. sold $98,978 worth of stock or 2,200 shares. The insider ENLOE ROBERT TED III sold $197,988.

Live Nation Entertainment, Inc. operates as a live entertainment company. The company has market cap of $10.23 billion. The firm operates through Concerts, Sponsorship & Advertising, Ticketing, and Artist Nation divisions. It currently has negative earnings. The Concerts segment promotes live music events in its owned and/or operated venues, and in rented third-party venues; operates and manages music venues; and produces music festivals and creates associated content.

More notable recent Live Nation Entertainment, Inc. (NYSE:LYV) news were published by: Prnewswire.com which released: “Gwen Stefani Debuts New Las Vegas Show “Gwen Stefani – Just a Girl” At Planet Hollywood Resort & Casino …” on June 29, 2018, also Streetinsider.com with their article: “Sirius XM (SIRI) & Live Nation (LYV) Combination is Possible – Citi” published on June 22, 2018, Globenewswire.com published: “Analysis: Positioning to Benefit within Cars, Iconix Brand Group, NRG Yield, Aramark, CBS, and Live Nation …” on June 13, 2018. More interesting news about Live Nation Entertainment, Inc. (NYSE:LYV) were released by: Globenewswire.com and their article: “JUNE 18 Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit …” published on June 15, 2018 as well as Prnewswire.com‘s news article titled: “Ticketmaster Helps Veterans Access Free And Discounted Live Event Tickets With Vet Tix Partnership” with publication date: June 21, 2018.

Investors sentiment decreased to 0.95 in 2018 Q1. Its down 0.20, from 1.15 in 2017Q4. It is negative, as 41 investors sold Live Nation Entertainment, Inc. shares while 112 reduced holdings. 47 funds opened positions while 98 raised stakes. 134.09 million shares or 1.99% less from 136.81 million shares in 2017Q4 were reported. 515,377 are held by Ny State Common Retirement Fund. Mutual Of America Cap Management Limited Co owns 0.07% invested in Live Nation Entertainment, Inc. (NYSE:LYV) for 111,093 shares. Cap Inv Counsel reported 0.24% in Live Nation Entertainment, Inc. (NYSE:LYV). Amundi Pioneer Asset has invested 0.04% in Live Nation Entertainment, Inc. (NYSE:LYV). City Holdings holds 0% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV) for 12 shares. Prelude Capital Management Limited Co stated it has 0.01% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV). Profund Advisors Llc reported 0.03% in Live Nation Entertainment, Inc. (NYSE:LYV). Rmb Ltd Liability holds 5,452 shares or 0.01% of its portfolio. Bnp Paribas Arbitrage holds 0% or 44,405 shares in its portfolio. Convergence Partners Limited Liability Corporation holds 759 shares. Advisory Serv Networks Limited Com accumulated 76 shares. Canada Pension Plan Inv Board accumulated 0.54% or 7.61M shares. Vanguard Grp Inc Inc stated it has 0.02% in Live Nation Entertainment, Inc. (NYSE:LYV). Howe Rusling reported 157 shares. San Francisco Sentry Group (Ca) invested 0% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV).

Among 17 analysts covering Edwards Lifesciences Corp (NYSE:EW), 13 have Buy rating, 0 Sell and 4 Hold. Therefore 76% are positive. Edwards Lifesciences Corp had 24 analyst reports since January 2, 2018 according to SRatingsIntel. Jefferies maintained Edwards Lifesciences Corporation (NYSE:EW) on Thursday, February 1 with “Buy” rating. The firm earned “Neutral” rating on Tuesday, January 2 by JP Morgan. Canaccord Genuity maintained it with “Buy” rating and $174.0 target in Thursday, February 15 report. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Buy” rating given on Wednesday, April 25 by Canaccord Genuity. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, February 1. The firm has “Hold” rating by Northland Capital given on Wednesday, April 25. RBC Capital Markets maintained the shares of EW in report on Friday, February 2 with “Buy” rating. On Tuesday, April 10 the stock rating was maintained by SunTrust with “Buy”. Cowen & Co maintained the stock with “Buy” rating in Thursday, February 1 report. The company was upgraded on Thursday, January 4 by Barclays Capital.

More important recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Prnewswire.com which released: “Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR” on June 28, 2018, also Ocbj.com published article titled: “Midday Stock Roundup”, Globenewswire.com published: “Report: Exploring Fundamental Drivers Behind Cabot Oil & Gas, Chesapeake Lodging Trust, CASI Pharmaceuticals …” on June 25, 2018. More interesting news about Edwards Lifesciences Corporation (NYSE:EW) was released by: Seekingalpha.com and their article: “Don’t Let Go Of Hasbro – Cramer’s Lightning Round (6/5/18)” with publication date: June 06, 2018.

Analysts await Edwards Lifesciences Corporation (NYSE:EW) to report earnings on July, 25. They expect $1.12 earnings per share, up 3.70% or $0.04 from last year’s $1.08 per share. EW’s profit will be $236.07M for 32.73 P/E if the $1.12 EPS becomes a reality. After $1.22 actual earnings per share reported by Edwards Lifesciences Corporation for the previous quarter, Wall Street now forecasts -8.20% negative EPS growth.

Maverick Capital Ltd increased Humana Inc (NYSE:HUM) stake by 8,730 shares to 45,140 valued at $12.14M in 2018Q1. It also upped Proto Labs Inc (NYSE:PRLB) stake by 19,068 shares and now owns 86,800 shares. Applied Matls Inc (NASDAQ:AMAT) was raised too.

Live Nation Entertainment, Inc. (NYSE:LYV) Institutional Positions Chart